Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer

Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer

Marseilles, France, December 6, 2017 — Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and developing cancer treatment drugs,…